Undervalued Or Overrated: Regado Biosciences Inc(RGDO), Newcastle Investment Corp.(NCT), BioScrip Inc(BIOS)?

Posted by admin February 13, 2015 0 Comment 1104 views

New York, NY – GDP INSIDER  –  02/13/2015.

This article discusses 3 companies Regado Biosciences Inc(NASDAQ:RGDO), Newcastle Investment Corp.(NYSE:NCT) and BioScrip Inc(NASDAQ:BIOS).

Regado Biosciences Inc(NASDAQ:RGDO) has been trading within a very narrow margin for the past few months even after it was announced that the biopharmaceutical company specialized in cardiovascular medicine is to merge with Tobira Therapeutics Inc. This will mark a change in direction to focus on treatments for liver and inflammatory diseases. The stock closed up $0.03 or 2.68% at $1.15 on one third lower trading volume than the 3 month average of 500,000. Unsurprisingly with the pending merger the price is staying close to the one year estimate of $1.00.

Will For Regado Biosciences Inc Maintain Declining Performance Or Will There Be A Rise? Get Our Free RGDO Analysis.

Newcastle Investment Corp.(NYSE:NCT) has been quite volatile over the last three months with the stock moving between its support value of just above $4 and the resistance line which seems to be around $5. Newcastle is a property investment trust that holds mortgage backed securities and funnels most of the profit it gains through to shareholders by way of large dividend yields. The stock has been on the rise since January 28 when it was at $4.20 and enjoyed further slight gains yesterday to close up 0.44% at $4.59, about half its 1yr target estimate of $10.63.

Where Is Newcastle Investment Corp Heading? To Understand The Details Of The Company, Click Here For Our Free NCT Analysis.

BioScrip Inc(NASDAQ:BIOS) the provider of home care management is still struggling to get out from under the cloud of an allegation from the beginning of 2014 that members of its executive management received kickback with Novartis Pharmaceuticals Inc. The matter was supposed to have been closed but was recently reopened by the Department of Justice prompting BioSrip to Appoint 3 new independent directors last week. The stock continued its slide yesterday closing down 0.65% at $6.10; however, if BioScrip can get clear of this issue then the stock should rally sharply.

What Does The Future Hold For BioScrip Inc? Understand The Fundamentals Of The Company Receiving Our Free BIOS Analysis.

About UltimateStockAlerts

UltimateStockAlerts.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.

Write Your Comment